Article Information
History
- October 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yuna Takatsuki1,†,
- Yuta Takahashi1,†,
- Jun Nakajima1,†,
- Yumi Iwasaki1,
- Katsutoshi Nagano1,
- Chihiro Tani-Sassa1,
- Sonoka Yuasa1,
- Saki Kanehira1,
- Kazunari Sonobe1,
- Yoko Nukui2,
- Hiroaki Takeuchi3,
- Kousuke Tanimoto4,5,
- Yukie Tanaka6,
- Akinori Kimura7,
- Naoya Ichimura1 and
- Shuji Tohda1,*
- 1Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan
- 2Infection Control and Prevention, Tokyo Medical and Dental University (TMDU) Hospital (currently Kyoto Prefectural University of Medicine)
- 3Department of Molecular Virology, Tokyo Medical and Dental University (TMDU)
- 4Genome Laboratory, Medical Research Institute, Tokyo Medical and Dental University (TMDU)
- 5Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU)
- 6Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU)
- 7Institute of Research, Tokyo Medical and Dental University (TMDU)
- ↵*Corresponding author:
Shuji Tohda, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan, Tel: 81-3-5803-5334; E-mail address: tohda.mlab{at}tmd.ac.jp
↵† These authors contributed equally
Posted October 28, 2022.
Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
